BUZZ-Akamai Technologies shares fall after announcing $2.2 billion convertible bond issuance
路透社2026/11/09 12:23November 9 - ** Cloud services company Akamai Technologies (AKAM.O) saw its share price fall by 7.3% in pre-market trading to $77 after reports that the company plans to raise capital.
** AKAM announced it will privately issue $1.1 billion in convertible bonds (CBs) maturing on November 15, 2028, and $1.1 billion in convertible bonds (CBs) maturing on November 15, 2031 (link).
** The company plans to use the net proceeds from this issuance to repay part of the $1.15 billion outstanding convertible bonds due in 2027 with a coupon rate of 0.375% at maturity, pay cash owed from early conversion of the 2027 convertible bonds, and fund capital expenditures for its cloud infrastructure services business.
** The company also plans to use part of the raised funds to pay for the costs of convertible bond hedge transactions.
** AKAM, headquartered in Cambridge, Massachusetts, has a market capitalization of around $12 billion.
** As of Friday's close, the company's share price had fallen about 5% year-to-date, while the S&P 500 Technology Index (.SPLRCT) rose by about 11%, and the Nasdaq Index (.IXIC) climbed nearly 6%.
** According to data from London Stock Exchange Group (LSEG), the average rating from 25 institutions is “buy”; the median target price is $120, down from $155.39 a month ago.
(To assist non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of the automated translated text and provides it solely for reader convenience. Reuters accepts no liability for any damages or losses caused by the use of the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nasdaq futures rise 1%, Dow Jones futures rise 1.1%

BUZZ-KKR shares rise as quarterly profit hits record high

Zura Bio's mid-stage clinical trial for skin disease drug fails
